Sabinsa highlights product innovation that solves common manufacturing challenges in booth # 4121
Sabinsa Corporation has always been a standard-bearer for product quality in the dietary supplements industry, so it’s no surprise that Marketing Director Shaheen Majeed will give two presentations on different aspects of achieving quality at Supple Side West this year.
Tuesday October 6th from 4:00 - 4:50pm Shaheen will co-present with Todd Pauli, Partner, strategic marketing, The Shelton Group on Leveraging Ingredient Quality to Build an Effective Content Marketing Strategy. Consumers are demanding to know exactly what is in their dietary supplements, and they want assurances that product labels match the bottle contents; this session will provide a road map to marketing product quality.
The second presentation by Shaheen, Exploring Global Supply Issues and Impact on Quality on Friday October 9th from 9:00 -10:30am at AHPA’s Botanical Congress, contains an overview of successful U.S. and global supply chain strategies, with a focus on availability, quality and adulteration challenges. The presentation will review current U.S. case histories and global supply disruption.
Vice President of Scientific Affairs Anurag Pande, PhD will introduce Sabinsa’s latest offering for cognitive heath, Sabroxy™, as part of Ingredient Launchpad at the SupplySide Central stage (booth 3183) on Wednesday October 7 12:35 – 12:40 PM.
Sabinsa’s booth 4121 will highlight the company’s shelf-stable probiotic, LactoSpore, for categories such as sport and immune health. For brands manufacturing their own products, for contract manufacturers or even for consumers tired of the orange color of Curcumin, Sabinsa has the solution: C3 Reduct®. Not only is it off-white in color, and has a lower dosage ratio when compared to regular doses of Curcumin, but it’s also the only correct metabolite available in the marketplace. From weight management ideas to healthy cognitive support ingredients, Sabinsa’s scientists in the booth can describe the ingredient options, all backed by science.
